Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and supply chain risks. Already registered? If you don't have a login or your access has expired, you ...

The General Court has handed a win to generic drug makers including Teva and Mylan in the battle over multiple sclerosis drug ...

The firm’s Technology & Engineering team will be expanded with an expert in patent drafting, prosecution and opposition/defence work across AI, digital health and medical devices. If you don't have a ...

Budget constraints and keeping up with advancing technology are the top challenges facing European life sciences patent ...

A biotech firm specialising in mRNA therapies alleges AbbVie’s $2.1 billion Capstan purchase was built on stolen lipid ...

24 June 2025 Coke Morgan Stewart has issued a raft of decisions under new guidance intended to improve the US patent appeals ...

There are varying national eligibility requirements that distinguish between treatments of and diagnostics for animals and ...

The pharma giant invalidates a university's patent while gaining FDA approval for a new subcutaneous version of Keytruda as it protects its $29.5-billion-a-year cancer drug ahead of a looming patent ...

US firm’s new partner “brings a rare combination of scientific depth, global perspective, and strategic legal insight” to her ...